AUGMEDIX


Associated tags: Patient, Hospital, Natural language processing, Physician, Health, SAN, Pharmaceutical industry

Locations: CHICAGO, LOS ANGELES, NEW YORK, CALIFORNIA, CANADA, UK, SAN FRANCISCO, CA, US, BENCHMARK, BEVERLY HILLS

Augmedix to Participate in Upcoming Investor Conferences in May and June 2024

Retrieved on: 
Friday, May 3, 2024

SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following four investor conferences in May and June 2024.

Key Points: 
  • SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following four investor conferences in May and June 2024.
  • RBC Capital Markets Global Healthcare Conference (New York): Management will participate in a fireside chat on May 15 at 10:30 a.m.
  • B. Riley Annual Institutional Investor Conference (Beverly Hills, CA): Management will participate in a fireside chat on May 22 at 9:00 a.m. PT, and be available for 1x1 investor meetings.
  • William Blair Annual Growth Stock Conference (Chicago): Management will participate in a fireside chat on June 5 at 8:40 a.m. CDT, and be available for 1x1 investor meetings.

Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List

Retrieved on: 
Thursday, April 25, 2024

SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, has been named on Newsweek’s list of The World’s Best Digital Health Companies 2024.

Key Points: 
  • SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, has been named on Newsweek’s list of The World’s Best Digital Health Companies 2024.
  • The World’s Best Digital Health Companies 2024 ranking lists the top 400 companies from over 35 different countries.
  • Based on the results of the study, Augmedix is proud to be recognized on Newsweek’s World’s Best Digital Health Companies 2024 list.
  • “Being recognized by Newsweek as one of the World's Best Digital Health Companies in 2024 is an honor for Augmedix.

Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments

Retrieved on: 
Wednesday, April 24, 2024

SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the country.

Key Points: 
  • SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the country.
  • As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits.
  • “Using Augmedix allowed me to spend more time with my patients and less time in front of my computer.
  • These AI models are utilized across different specialties and sections of the note to deliver high quality medical documentation.

Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care

Retrieved on: 
Tuesday, April 9, 2024

The alliance aims to harness the power of ambient documentation to transform the clinician-patient interaction landscape in mission-critical virtual care settings.

Key Points: 
  • The alliance aims to harness the power of ambient documentation to transform the clinician-patient interaction landscape in mission-critical virtual care settings.
  • As part of this collaboration, Andor and Augmedix will integrate physician clinical note creation directly within ThinkAndor® Virtual Visit capability for ambulatory with an AI-generated note available seconds after the virtual session.
  • Andor Health is changing the way care teams connect and collaborate with AI-instrumented and tailored workflows.
  • "The Andor-Augmedix approach is focused on unobtrusive integration wherein the ambient documentation is part of the native virtual workflow and end-user experience paradigm.

Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide

Retrieved on: 
Thursday, April 4, 2024

The collaboration is focused on leveraging the companies’ combined technology expertise and expanding their reach to provide greater product and service value to health systems seeking high-quality ambient documentation and structured data products.

Key Points: 
  • The collaboration is focused on leveraging the companies’ combined technology expertise and expanding their reach to provide greater product and service value to health systems seeking high-quality ambient documentation and structured data products.
  • “Together, we can accelerate efforts to bring ambient medical documentation and data solutions to benefit more patients and clinicians.”
    SADA provides cloud, data, artificial intelligence, cybersecurity, and intelligent edge solutions and services.
  • "Augmedix's partnership with SADA will help bring ambient documentation to more healthcare organizations around the country," said Amy Waldron, global director of Healthcare Strategy & Solutions, Google Cloud.
  • This collaboration underscores our commitment to empowering organizations like Augmedix and SADA to drive meaningful change in the healthcare industry."

Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023

Retrieved on: 
Monday, March 18, 2024

Total revenue was $12.7 million, slightly stronger than our January pre-announcement and an increase of 45% compared to $8.8 million.

Key Points: 
  • Total revenue was $12.7 million, slightly stronger than our January pre-announcement and an increase of 45% compared to $8.8 million.
  • Adjusted operating expenses, a Non-GAAP metric, increased 12% to $9.9 million compared to $8.8 million.
  • Cash and cash equivalents as of December 31, 2023, was $46.2 million compared to $21.3 million as of December 31, 2022.
  • ET / 1:30 p.m. PT today, Monday, March 18, 2024, to discuss its fourth quarter and full year 2023 financial results.

Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go

Retrieved on: 
Tuesday, March 12, 2024

SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced new positive data and product enhancements for Augmedix Go , its ambient AI medical documentation product.

Key Points: 
  • SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced new positive data and product enhancements for Augmedix Go , its ambient AI medical documentation product.
  • Now supporting over 50 medical specialties, the Augmedix Go mobile app optimizes ambient AI technology to produce comprehensive draft medical notes in real time by processing the natural conversations between clinicians and patients.
  • Additionally, 94% of clinicians surveyed reported that Augmedix Go helps them better focus on their patients.
  • By utilizing multiple models that cross-check each other, Augmedix is delivering high quality notes that instill trust among clinicians.

Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024

Retrieved on: 
Friday, March 8, 2024

SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will release fourth quarter and full year 2023 results after the market closes on Monday, March 18, 2024.

Key Points: 
  • SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will release fourth quarter and full year 2023 results after the market closes on Monday, March 18, 2024.
  • Following the release, management will host a conference call and audio webcast to review results and provide a brief business and outlook update that same day at 1:30 p.m. PT / 4:30 p.m.
  • ET.

Augmedix to Participate in Citizens JMP Technology Conference

Retrieved on: 
Tuesday, February 27, 2024

SAN FRANCISCO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that members of its management team will participate in a fireside chat and host investor meetings at the Citizens JMP Technology Conference taking place in San Francisco on March 4, 2024.

Key Points: 
  • SAN FRANCISCO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that members of its management team will participate in a fireside chat and host investor meetings at the Citizens JMP Technology Conference taking place in San Francisco on March 4, 2024.
  • The fireside chat will be held at 11 a.m. PT / 2 p.m.
  • Company management will also be participating in one-on-one investor meetings at the conference.
  • To schedule a meeting, please submit a request on the conference website, contact your Citizens JMP representative, or email Augmedix’s IR team FNK IR at [email protected] .

Augmedix Names Tomer Levy as New Senior Vice President of Engineering

Retrieved on: 
Tuesday, February 13, 2024

SAN FRANCISCO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that Tomer Levy joined the company in January 2024 in the newly-created Senior Vice President of Engineering role.

Key Points: 
  • SAN FRANCISCO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that Tomer Levy joined the company in January 2024 in the newly-created Senior Vice President of Engineering role.
  • “We are thrilled to have Tomer join Augmedix as we continue to push the boundaries of AI-powered medical documentation technology to alleviate administrative burden,” said Manny Krakaris, CEO of Augmedix.
  • “Tomer has a distinguished career managing complex, global infrastructures, and having him on the Augmedix team will allow us to optimize engineering performance, streamline product development, and accelerate scalability to health systems across the nation.
  • Tomer's ownership of our production systems will enable our CTO, Saurav Chatterjee, to focus on pushing the frontiers of AI technology embedded in our platform.”
    Prior to joining Augmedix, Levy most recently served as Senior Vice President of Research and Development at Change Healthcare.